PHILADELPHIA--(BUSINESS WIRE)--DaVita Inc. (NYSE: DVA), a leading provider of kidney care services committed to improving the quality of life for those diagnosed with chronic kidney disease (CKD), today announced the presentation of 11 studies at this year’s American Society of Nephrology’s (ASN) Kidney Week. DaVita® will be at booth 1801 during the November 8-13 meeting in Philadelphia.